- Higher Febuxostat Exposure Observed in Asian Compared with Caucasian Subjects Independent of Bodyweight
Dinko Rekić et al, 2021, Clinical Pharmacokinetics CrossRef - Simulation of febuxostat pharmacokinetics in healthy subjects and patients with impaired kidney function using physiologically based pharmacokinetic modeling
Yichao Xu et al, 2022, Biopharmaceutics & Drug Disposition CrossRef - Population pharmacokinetic modelling of febuxostat in healthy subjects and people with gout
Bishoy Kamel et al, 2022, British Journal of Clinical Pharmacology CrossRef - Concomitant febuxostat enhances methotrexate-induced hepatotoxicity by inhibiting breast cancer resistance protein
Kenji Ikemura et al, 2019, Scientific Reports CrossRef - The current treatment strategy for gouty arthritis
M. S. Petrova et al, 2018, Modern Rheumatology Journal CrossRef - Febuxostat for the chronic management of hyperuricemia in patients with gout
Sandra Pamela Chinchilla et al, 2016, Expert Review of Clinical Pharmacology CrossRef - Determination of febuxostat in human plasma by high performance liquid chromatography (HPLC) with fluorescence-detection
Bishoy Kamel et al, 2019, Journal of Chromatography B CrossRef - A sensitive HPLC-FL method to simultaneously determine febuxostat and diclofenac in rat plasma: assessment of metabolic drug interactions in vitro and in vivo
Dong-Gyun Han et al, 2020, Analytical Methods CrossRef - A pharmacokinetic‐pharmacodynamic study of a single dose of febuxostat in healthy subjects
Bishoy Kamel et al, 2020, British Journal of Clinical Pharmacology CrossRef - Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat
Bishoy Kamel et al, 2017, Clinical Pharmacokinetics CrossRef - Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat
Andreas Jordan et al, 2018, Pharmaceuticals CrossRef - Previous Dosage of Allopurinol Is a Strong Determinant of Febuxostat Efficacy
Hiroyoshi Koide et al, 2017, Biological & Pharmaceutical Bulletin CrossRef